Article
Advances in Pediatric Acute Promyelocytic Leukemia
2 Feb 2020
Abstract excerpt
Acute promyelocytic leukemia (APL) is a rare disease accounting for only 5%–10% of pediatric acute myeloid leukemia (AML) and fewer than 1000 cases occur annually in the United States across all age groups. Characterized by t (15; 17), with a resultant PML-RARA gene fusion driving leukemia development, advances in therapy have improved outcomes for APL significantly in the past several decades, now making APL the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
